Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_03494 |
| Species: | Mus musculus |
| Position : | chr11:32165011-32165922 |
| Year: | 2007 |
| Title: | Tissue-specific histone modification and transcription factor binding in alpha globin gene expression. |
| Genome Build: | mm9 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| PMID: | 17715390 |
| Tissue: | spleen |
| Tissue Ontology ID: | UBERON:0002106 |
| Cell Source: | Primary erythroid cells from humanized mouse |
| Cell Type: | erythroblast |
| Cell Ontology ID: | CL:0000765 |
| Experiment Type: | TF binding assay; Chromatin modification assay; In vivo functional validation |
| Low Throughput Method: | ChIP-qPCR; In vivo phenotyping |
| Target gene : | Hba-a1 |
| TF name : | Tal1 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_02494 | chr11:32145540-32169344 | NA | primitive erythroid lineage cell | NA |
| E_02495 | chr11:32145540-32169344 | NA | primitive erythroid lineage cell | NA |
| E_00112 | chr11:32165011-32165922 | liver | erythroblast | NA |
| E_00113 | chr11:32165011-32165922 | liver | erythroblast | NA |
| E_00114 | chr11:32165011-32165922 | liver | erythroblast | NA |
| E_00115 | chr11:32165011-32165922 | liver | erythroblast | NA |
| E_00116 | chr11:32165011-32165922 | liver | erythroblast | NA |
| E_00117 | chr11:32165011-32165922 | liver | erythroblast | NA |
| E_00118 | chr11:32165011-32165922 | liver | erythroblast | NA |
| E_00119 | chr11:32165011-32165922 | liver | erythroblast | NA |
| E_03322 | chr11:32165011-32165922 | liver | erythroid cell | NA |
| E_03490 | chr11:32165011-32165922 | spleen | erythroblast | NA |
| E_03491 | chr11:32165011-32165922 | spleen | erythroblast | NA |
| E_03492 | chr11:32165011-32165922 | spleen | erythroblast | NA |
| E_03493 | chr11:32165011-32165922 | spleen | erythroblast | NA |
| E_03495 | chr11:32165011-32165922 | spleen | erythroblast | NA |